Project Grant R21OH012948
- This $249,614 federal Project Grant award from the National Institute for Occupational Safety and Health (part of the Centers for Disease Control and Prevention) under the CDC Investigations and Technical Assistance program (CFDA 93.283) is for the Icahn School of Medicine at Mount Sinai to conduct research on "Decoding Spatial and Cellular Heterogeneity in Recurrence of WTC-Related Prostate Cancer". The award period is from July 1, 2025 to June 30, 2027. The grant supports research to...
- This $246,387 Project Grant was awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to New York University (NYU) School of Medicine. The grant, with a performance period from July 1, 2025 to June 30, 2027, will fund research to investigate tissue molecular profiles in the World Trade Center (WTC)-exposed community in New York. As a leading academic medical center, NYU has demonstrated extensive capabilities in...
- The Icahn School of Medicine at Mount Sinai received a $172,764 Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to study the relationship between the liver, metabolic syndrome, and increased cardiovascular disease risk among African American World Trade Center general responders. The award will support research and investigations focused on this public health topic over a 2-year period from July 1, 2025...
- This federal Project Grant award of $249,150.00, provided by the National Institute for Occupational Safety and Health (NIOSH) under the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283), is funding a research project at the Icahn School of Medicine at Mount Sinai (ISMMS) to evaluate frailty and obesity in World Trade Center general responders. The research aims to utilize measures of physiologic and metabolic function to better...
- This federal Project Grant award of $282,297.00 was provided by the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to the Albert Einstein College of Medicine. The grant will fund research on "Blood Mutations and Cancer Associations Among WTC-Exposed Firefighters" over a 2-year period from July 1, 2025 to June 30, 2027. The research project will be conducted at the awardee's location in New York, USA. Albert Einstein...
- The National Institute for Occupational Safety and Health (NIOSH), a civilian agency under the Centers for Disease Control and Prevention (CDC), awarded a $219,932 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Icahn School of Medicine at Mount Sinai. This 2-year grant, awarded on July 1, 2025, supports research on premature biological aging among World Trade Center responders. As a leading academic medical center, the Icahn School of Medicine at...
- This federal Project Grant award of $202,800 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York. The award is focused on "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis" and will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award...
- This $274,246 federal Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) supports a study titled "Episodic Memories of 9/11 Terror Attack and Mental Health: Natural Language Processing of Adolescent and Adult Survivors' Narratives (EMLAS Study)." The award, which runs from July 1, 2025 to June 30, 2027, will fund research by the Research Foundation For Mental Hygiene, Inc. (RFMH), a nonprofit...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $1,014,000.00 to the Icahn School of Medicine at Mount Sinai to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The research, which is scheduled to take place from September 1, 2024 to August 31, 2028, will leverage the institution's expertise in areas such as cancer biology, immunology, and clinical...
- This federal Project Grant award for $147,573 from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) will support research on posttraumatic stress disorder (PTSD) and physical functional decline among aging World Trade Center responders. The research will be conducted by the Research Foundation for the State University of New York, doing business as Stony Brook University, over a project period from July 1, 2025 to June 30, 2028....
This federal Project Grant award of $250,953 from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) supports the "UPDATE OF THE WTC CANCER TISSUE BIOBANK" at the Icahn School of Medicine at Mount Sinai (ISMMS) in New York. The award will fund research activities and technical assistance related to the management and enhancement of the WTC (World Trade Center) Cancer Tissue Biobank over the period of July 1, 2025 to June 30, 2027. ISMMS, a prominent academic medical center and research institution, has an extensive track record of receiving federal grants from agencies like the National Institutes of Health to conduct sophisticated medical research across various disciplines, including cancer research and precision medicine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $251.0k | 8/4/25 |